Alzeca Biosciences, LLC

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Alzeca Biosciences, LLC
Quantité totale PI 8
Rang # Quantité totale PI 197 878
Note d'activité PI 1,6/5.0    6
Rang # Activité PI 157 731

Brevets

Marques

4 0
0 0
4 0
0
 
Dernier brevet 2023 - Targeted contrast agents for mri...
Premier brevet 2012 - Lipid-based nanoparticles

Derniers inventions, produits et services

2023 Invention Targeted contrast agents for mri of alpha-synuclein deposition. A liposomal composition (“ADx-00...
2022 Invention Functionalized liposomes for imaging misfolded proteins. Phospholipid-polymer-aromatic conjugate...
Invention Targeting ligands for tau pathology. Methods and compositions for detecting tau pathology are des...
Invention Targeted contrast agents for mri of alpha-synuclein deposition. A liposomal composition (“ADx-003...
2021 Invention Targeted contrast agents for mri of alpha-synuclein deposition. 2221234356732321646577 is -H, or ...
2020 Invention Targeting ligands for tau pathology. Methods and compositions for detecting tau pathology are de...
Invention Functionalized liposomes for imaging misfolded proteins. Phospholipid-polymer-aromatic conjugates...
2017 Invention Lipid-based nanoparticles. Lipid-based nanoparticle compositions are provided. The compositions g...
2013 Invention Methods and compositions for objectively characterizing medical images. Methods and compositions ...